FDA Authorizes Changes to Simplify Use of Bivalent mRNA COVID-19 Vaccines. Ignores VAERS Data

Dr. Wiseman discusses the U.S. Food and Drug Administration's amendment of the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered to individuals 6 months of age and older, including for an additional dose or doses for certain populations. The monovalent Moderna and Pfizer-BioNTech COVID-19 vaccines are no longer authorized for use in the United States.
------------------------------------
Join The Conversation! | https://trialsitenews.com/